Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Innovent Receives Approval of DOVBLERON® (Taletrectinib Adipate Capsule, ROS1 Inhibitor) by China's National Medical Products Administration 2024-12-20 20:20
1